Clinical Trials Browser

Recruiting × INDUSTRY × deucravacitinib × Clear all

NCT07256015 2025-12-01

Deucravacitinib for Patients With Moderate/Severe Psoriasis: A Real-Life Experience in Italy

Lymphoma, Follicular, Psoriasis